Patent · US Active

Disubstituted phthalazine hedgehog pathway antagonists

US8273742B2 · kind B2 · utility

2Cited by
1References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 15, 2010
Grant dateSep 25, 2012
Priority date
Expiry dateFeb 25, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides novel 1,4-disubstituted phthalazine hedgehog pathway antagonists useful in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.